RankingsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. Diluted EPS

HISAMITSU PHARMACEUTICAL CO.,INC.【JP:4530】

Market cap
¥548.5B
P/E ratio
21.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Feb 28, 2025295.2+62.69%
Feb 29, 2024181.4+22.68%
Feb 28, 2023147.9+24.44%
Feb 28, 2022118.8+5.07%
Feb 28, 2021113.1-50.24%
Feb 29, 2020227.3-1.11%
Feb 28, 2019229.9+0.66%
Feb 28, 2018228.4-5.31%
Feb 28, 2017241.2+15.52%
Feb 29, 2016208.8-4.80%
Feb 28, 2015219.3-12.04%
Feb 28, 2014249.3+13.55%
Feb 28, 2013219.6+2.08%
Feb 29, 2012215.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)